In the TCGA study, the CLDN18-ARHGAP26 fusion gene was found to be existed in GS/diffuse GC [12], and it could promote epithelial-mesenchymal transition and enhance the invasion and metastasis ability of tumor cells, thereby affecting the prognosis of patients. This evidence concerns the gene CLDN18 and gastric cancer.